Belviq Weight Loss Review

Several pharmaceutical products targeting obesity have entered the market in recent years, including the now-discontinued Belviq weight-loss tablet. This medication was prescribed for patients with a body mass index (BMI) placing them in the clinically obese category.

What was Belviq used for, and is it still available? We researched this prescription weight-loss drug thoroughly to help you understand its history and any current alternatives.

What Is Belviq?

The 10mg tablet targeted appetite receptors in the hypothalamus to promote satiety, potentially reducing food intake and supporting weight loss.

• Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy: lorcaserin (sold as Belviq) genuinely affects 5-HT2C receptors, increasing satiety while decreasing food intake, reducing weight with or without other coexisting conditions.
• Journal of Pharmacology & Pharmacotherapeutics: at therapeutic doses, lorcaserin genuinely acts as a 5-HT2C agonist, triggering alfa-MSH release that reduces appetite via the hypothalamus.
• Clinical Obesity: the FDA indicated lorcaserin for chronic weight management in adults with obesity or overweight plus at least one comorbidity, with efficacy and safety genuinely established across the BLOOM, BLOSSOM, and BLOOM-DM Phase III trials.

Who Makes Belviq?

Eisai Co., Ltd., a Japanese pharmaceutical company founded in 1941 by Toyoji Naito, developed Belviq. Its American subsidiary, Eisai Inc., was established in New Jersey in 1997, developing, manufacturing, and marketing prescription medicines, generics, and OTC drugs globally.

Eisai Inc. Customer Service and Belviq Reviews

No product reviews or ratings exist, particularly post-recall — the company shows no presence on Trustpilot or Yelp.

Global Headquarters: Eisai Co., Ltd., 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan. Phone: +81-3-3817-3700.

US Headquarters: Eisai Inc., 200 Metro Blvd, Nutley, NJ 07110. Phone: (201) 692-1100. Fax: (201) 746-2600.

The Relationship Between Belviq and the Better Business Bureau

Eisai Inc. holds an A+ BBB rating (file opened September 2001) without accreditation, with no current customer reviews. No complaints in the last 12 months and none resolved in the previous three years.

What Belviq Claims Did We Find?

Eisai marketed Belviq for obesity-related weight loss, prescribable for patients with a BMI of 31+ or 27-30 with at least one obesity-related condition. The drug activated brain serotonin receptors linked to appetite, promoting feelings of fullness.

What Are the Belviq Ingredients?

The active ingredient was lorcaserin hydrochloride. Inactive ingredients in each blue film-coated tablet included:

• Silicified microcrystalline cellulose
• Hydroxypropyl cellulose NF
• Croscarmellose sodium NF
• Colloidal silicon dioxide NF
• Polyvinyl alcohol USP
• Polyethylene glycol NF
• Titanium dioxide USP
• Talc USP
• FD&C blue #2 aluminum lake
• Magnesium stearate VF

Does Belviq Work? Belviq Weight Loss Benefits

Per Obesity Reviews, adding pharmacotherapy like lorcaserin to lifestyle intervention genuinely produced greater, more sustained weight loss than lifestyle changes alone.

The Journal of Clinical Endocrinology & Metabolism‘s BLOSSOM trial analysis found lorcaserin plus lifestyle modification genuinely produced dose-dependent weight loss significantly greater than placebo.

A 2019 study in Diabetes, Obesity, and Metabolism found lorcaserin-treated patients showed genuine improvements in atherogenic lipoproteins, correlating with better cardiovascular risk markers alongside reduced central adipose tissue.

Beyond obesity, Pharmacology & Therapeutics notes lorcaserin may genuinely hold broader therapeutic potential across other health conditions, based on multiple data sources.

In February 2020, the FDA requested Eisai voluntarily recall Belviq. Per Expert Opinion on Pharmacology, reintroduction without further carcinogenic-risk trials appears genuinely unlikely.

Are There Potential Belviq Side Effects?

Common side effects included back pain, constipation, cough, dry mouth, headache, and tiredness.

More serious effects requiring immediate medical attention included agitation, blurred vision, breast swelling, confusion, diarrhea, dizziness, dry eyes, irregular heartbeat, fainting, dissociative feelings, fever, hallucinations, lightheadedness, loss of coordination, memory problems, nausea, nipple discharge, ongoing weakness, overactive reflexes, prolonged painful erection, sweating, extremity swelling, thoughts of self-harm, tremors, breathing trouble, difficulty concentrating, unusual mood changes, severe muscle stiffness, and vomiting.

How to Take Belviq

Can I Take Belviq With…

The FDA requested Eisai withdraw Belviq from the American market. Patients using it or a replacement should have already discussed potential drug interactions with their doctor before starting or stopping any medication or supplement, particularly with underlying health conditions.

Where to Buy Belviq and the Cost

Belviq is no longer available for purchase. It was previously prescription-only before the 2020 voluntary recall; reliable pricing or insurance coverage information from that era isn’t currently available.

Can You Cancel My Belviq Prescription?

We can’t cancel prescriptions or replacement orders through manufacturers or pharmacies — contact the pharmacy your prescription is through.

What About the Belviq Recall?

Per the British Medical Journal, the FDA requested Eisai voluntarily withdraw the drug on February 13, 2020, following observed increases in rapidly growing cells linked to serious health complications in patients using it.

The Pros and Cons of Belviq

Pros

• Was marginally effective at controlling appetite
• Designed for long-term use in obesity management
• Oral format appealed to those avoiding injections

Cons

• Required meeting specific BMI criteria for prescription
• FDA requested suspension due to genuine health concerns
• No longer available in North America

What’s the Bottom Line on Belviq?

Belviq’s drug class — CNS stimulants, anorexiants, and serotonin 5-HT2C-receptor agonists — showed genuine potential for promoting satiety and reducing food intake, appealing to patients who preferred oral medication over injectables.

Belviq is discontinued — Eisai’s voluntary recall took effect in February 2020 at the FDA’s request, and ongoing litigation continues around the drug.

Weight loss doesn’t require a prescription drug in most cases. A comprehensive, clinically-backed program with personalized coaching and structured behavioral support offers a genuinely more sustainable path toward lasting results.

Explore more New reviews and guides on our site.